8-KRegulation FDExhibits & Filings

CVS HEALTH Corp 8-K Report, Regulation FD Disclosure (Jun 4, 2019)

Filed June 4, 2019For Securities:CVS

Summary

CVS Health Corporation filed an 8-K on June 3, 2019, primarily to disclose information presented at its 2019 Investor Day held on June 4, 2019. The company issued a press release that touched upon its key enterprise priorities and, importantly, reaffirmed its full-year 2019 financial projections. This reaffirmation suggests continued confidence in achieving previously stated targets amidst ongoing integration and strategic initiatives. Furthermore, the press release provided initial financial projections for the fiscal year 2020. While specific details are contained within the furnished press release (Exhibit 99.1), the act of providing 2020 guidance indicates a forward-looking perspective and management's intent to offer visibility into the company's expected performance beyond the current fiscal year. Investors should review the referenced press release for a comprehensive understanding of these strategic priorities and financial outlooks.

Key Highlights

  • 1CVS Health hosted its 2019 Investor Day on June 4, 2019.
  • 2A press release was issued in connection with the Investor Day, furnished as Exhibit 99.1.
  • 3The company reaffirmed its full-year 2019 financial projections.
  • 4Initial financial projections for the fiscal year 2020 were provided.
  • 5The filing does not represent a change in financial statements but rather an update on forward-looking information.
  • 6The disclosed information is not considered 'filed' for the purposes of Section 18 of the Exchange Act.

Frequently Asked Questions